News blog

Fastnet Oil & Gas

  • BY: Andrew Hore |
  • POSTED: 11/08/2015 |

Fastnet Oil & Gas is exiting the oil business and seeking a healthcare acquisition. 

Fastnet will not be spending any more, beyond existing commitments, on oil exploration in Morocco or the Celtic Sea, where it has failed to sign-up a partner. 

There was $15.9m left in the bank at the end of July 2015, which had fallen from $18.8m at the end of September 2014. There are $600,000 of liabilities to take into account but the fixed assets, mainly capitalised exploration spending, are likely to be written off.

Annual overheads have been running at $1.9m and they should fall to less than $600,000 a year.

The share price rose 0.08p to 2.1p, which values Fastnet at £7.3m. That suggests a discount to cash of around one-quarter.

The main focus will be biopharma companies Europe that already have a strong management and products that have significant commercial potential. They should at least be near to generating revenues so a business with early stage products in development would not fit the bill.

There are plans to make new appointments to the board. Non-executive director Cathal Friel has more than doubled his stake to £11.5m, although he was buying shares at 4p each.

The company is changing its name to Fastnet Equity. 

© 2021 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds